Myriad Genetics Inc. Newsletter
-
At-Home Genetic Testing Market Analysis 2025 – Insights For Long-Term Investment & Planning
04 Jul 2025 09:44 GMT
… Market?
Labcorp Holdings Inc., AncestryDNA, Myriad Genetics Inc., 23andMe Inc., LetsGetChecked, Helix …
-
Rising Lifestyle-Related Incidences Drive Growth in the Biomarker Market: A Key Trend Shaping 2025 Outlook
04 Jul 2025 08:56 GMT
… Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino …
-
INVESTOR ALERT: Investigation of Myriad Genetics, Inc. (MYGN) Announced by Holzer & Holzer, LLC
25 Jun 2025 17:04 GMT
… ; Holzer, LLC is investigating whether Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ … laws. On May 6, 2025, Myriad Genetics reported first quarter 2025 financial … stock dropped. If you purchased Myriad Genetics stock and suffered a loss …
-
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
03 Jun 2025 13:00 GMT
… Raha, President and CEO, Myriad Genetics. “Our introduction of FirstGene … , PhD, Chief Scientific Officer, Myriad Genetics. “We meticulously developed a suite … manage their pregnancies. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic …
-
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
02 Jun 2025 13:00 GMT
… 02, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a … Muzzey, PhD, chief scientific officer, Myriad Genetics. “Precise MRD is informed by … the patient care continuum.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic …
-
Indian American Balaji Srinivasan edges closer to “Network State” with island school
03 Jul 2025 17:06 GMT
… Counsyl, (later on acquired by Myriad Genetics for $375 million in 2018 …
-
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
27 May 2025 20:05 GMT
… PhD, chief scientific officer, Myriad Genetics. “The research efforts we’re … Chief Clinical Officer, Oncology, Myriad Genetics. “These efforts are evidenced … patient care continuum. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic …
-
Myriad Genetics downgraded to Sector Perform from Outperform at Scotiabank
21 May 2025 05:48 GMT
-
Efficacy and Toxicity Seen With MIRV in Ovarian Cancer
03 Jul 2025 09:24 GMT
… Sharp & Dohme, Mersana Therapeutics, Myriad Genetics, Novocure GmbH, OncXerna Therapeutics, PharmaMar …
-
Updated: Myriad Genetics To Participate In Two Upcoming Investor Healthcare Conferences
14 May 2025 21:46 GMT
… 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader … at investor.myriad.com . About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic … and well-being for all. Myriad Genetics develops and offers molecular tests …